Related Experiment Video

Updated: Oct 27, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

In Search of Effective Anticancer Agents-Novel Sugar Esters Based on Polyhydroxyalkanoate Monomers

Wojciech Snoch1, Dawid Wnuk2, Tomasz Witko1

  • 1Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Kraków, Poland.

International Journal of Molecular Sciences
|July 20, 2021
PubMed

Insights

New sugar fatty acid esters (SFAEs) show potential as anticancer agents. These compounds demonstrated cytotoxicity against melanoma and prostate cancer cells without promoting metastasis, suggesting a promising alternative for cancer therapy.

Area of Science:

  • Biochemistry
  • Organic Chemistry
  • Cancer Biology

Background:

  • Cancer remains a leading global cause of death, necessitating novel therapeutic strategies.
  • Existing cancer treatments, including targeted and personalized therapies, face limitations in efficacy and accessibility.
  • Sugar fatty acid esters (SFAEs) are emerging as potential alternative therapeutic agents.

Purpose of the Study:

  • To explore the synthesis and anticancer properties of novel SFAEs.
  • To investigate the influence of SFAE hydrophobic chain modifications on cytotoxicity against cancer cell lines.
  • To evaluate the metastatic potential of SFAEs at non-cytotoxic concentrations.

Main Methods:

  • Synthesis of various SFAEs using combined biological, chemical, and enzymatic approaches.
  • Cytotoxicity assessment using MTT assays against human skin melanoma and prostate cancer cell lines.
  • Evaluation of metastatic properties by examining microtubule polymerization and actin filament depolymerization.

Main Results:

  • Newly synthesized SFAEs exhibited IC50 values ranging from 63.3 to 1737.6 μM.
  • Lactose-based SFAEs demonstrated significant potential as effective surfactants.
  • Observed low microtubule polymerization and actin filament depolymerization suggest apoptotic rather than metastatic effects.

Conclusions:

  • SFAEs show promise as anticancer agents, with no observed propensity for metastasis in cancer cells.
  • Lactose-based SFAEs are identified as particularly promising candidates among the tested sugar esters.
  • This research establishes a foundation for developing novel anticancer agents derived from 3-hydroxylated fatty acids of bacterial origin.
Keywords:
anticancer agentschemical modificationsfluorinationmelanomapolyhydroxyalkanoatesprostate cancersugar esters

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.2K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.5K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
330
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
498